Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Shandong New Time Pharmaceutical Co., LTD)"
Count: 11
Selected: 0
| NCT ID | Title |
|---|
| NCT05408221 | Phase Ⅱ/III Studies to Investigate the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib Compared to Placebo in Combination With Lenvatinib as First-Line Therapy in Subjects With Hepatocellular Carcinoma (HCC) | ||
| NCT05305183 | A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis | ||
| NCT05293028 | Study of F527 in Patients With Relapsed or Refractory Lymphoma | ||
| NCT05178836 | A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL | ||
| NCT05076474 | Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg | ||
| NCT05040906 | A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients | ||
| NCT04984434 | Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT04636515 | A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma | ||
| NCT04457869 | A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL) | ||
| NCT04457830 | The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL). | ||
| NCT03657381 | Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520 |
